The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 11, 2017
Filed:
Mar. 05, 2014
Applicant:
Taiho Pharmaceutical Co., Ltd., Tokyo, JP;
Inventors:
Satoshi Fukaya, Ibaraki, JP;
Toshihiro Osada, Ibaraki, JP;
Hiroshi Wada, Ibaraki, JP;
Teruhiro Utsugi, Ibaraki, JP;
Assignee:
Taiho Pharmaceutical Co., Ltd., Tokyo, JP;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/00 (2006.01); C07K 14/47 (2006.01); A61K 39/00 (2006.01); C07K 14/82 (2006.01);
U.S. Cl.
CPC ...
C07K 14/4748 (2013.01); A61K 39/0011 (2013.01); C07K 14/82 (2013.01); A61K 2039/572 (2013.01); A61K 2039/70 (2013.01); C07K 2319/00 (2013.01); C07K 2319/33 (2013.01);
Abstract
This invention provides a cancer antigen peptide that can be administered to a wide range of cancer patients in the form of a peptide vaccine for cancer without the need for HLA typing and regardless of the HLA types of patients. Such peptide having 5 linked CTL epitopes is obtained by linking 5 CTL epitope peptides selected from among CTL epitope peptides derived from tumor antigen molecules that are reported to have the capacity for CTL induction via linkers.